Growth Metrics

Dare Bioscience (DARE) Depreciation and Depletion (2020 - 2024)

Dare Bioscience's Depreciation and Depletion history spans 5 years, with the latest figure at $6043.0 for Q4 2024.

  • For Q4 2024, Depreciation and Depletion fell 39.45% year-over-year to $6043.0; the TTM value through Dec 2024 reached $42000.0, up 9.48%, while the annual FY2025 figure was $162000.0, 285.71% up from the prior year.
  • Depreciation and Depletion reached $6043.0 in Q4 2024 per DARE's latest filing, down from $9742.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $15437.0 in Q2 2024 to a low of $3034.0 in Q3 2022.
  • Average Depreciation and Depletion over 5 years is $8710.2, with a median of $9384.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: tumbled 52.17% in 2022, then surged 205.21% in 2023.
  • A 5-year view of Depreciation and Depletion shows it stood at $6799.0 in 2020, then rose by 3.65% to $7047.0 in 2021, then skyrocketed by 50.73% to $10622.0 in 2022, then decreased by 6.04% to $9980.0 in 2023, then crashed by 39.45% to $6043.0 in 2024.
  • Per Business Quant, the three most recent readings for DARE's Depreciation and Depletion are $6043.0 (Q4 2024), $9742.0 (Q3 2024), and $15437.0 (Q2 2024).